BT

Bjørn Tore

Mutual Connections
Loading...
S9-052025-1213923

Send Message

No file chosen
1 Publications
0 Followers
0 Following
0 Questions

👤 About

Skills & Expertise

No skills added yet.

Research Interests

No research interests added yet.

Connect With Me

📚 Publications (1)

Journal: Leukemia & Lymphoma • March 2025
Chronic myeloid leukemia (CML) is a hematopoietic stem cell malignancy, driven by the pathognomonic oncogenic fusion protein BCR::ABL1. Tyrosine kinase inhibitors (TKIs) targeting ABL1 have increased...
Signaling Phosphorylation Tyrosine kinase inhibitor Leukemic stem cells Tumor micro environment Chronic myeloid leukemia
dd